サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1243323

ヘルスケアミドルウェアの世界市場

Healthcare Middleware
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
ヘルスケアミドルウェアの世界市場
出版日: 2023年03月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアミドルウェアの世界市場は2030年に58億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に31億米ドルと推定されるヘルスケアミドルウェアの世界市場は、2030年には58億米ドルに達すると予測され、2022年から2030年にかけてCAGR8.1%の成長を遂げると予測されます。本レポートで分析したセグメントの一つであるプラットフォームミドルウェアは、CAGR6.8%を記録し、分析期間終了時には24億米ドルに達すると予測されます。パンデミック後の回復が進んでいることを考慮し、統合ミドルウェア分野の成長は、今後8年間のCAGRを9.1%に修正しました。

米国市場は9億4,230万米ドル、中国はCAGR7.6%で成長すると予測

米国のヘルスケアミドルウェア市場は、2022年に9億4,230万米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが7.6％となり、2030年には10億米ドルの市場規模に達すると予測されます。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ7.5％と6.7％の成長が予測されています。欧州では、ドイツがCAGR約6.8%で成長すると予測されています。

調査対象企業の例

  • Ascom Holding AG
  • Cerner Corporation
  • Corepoint Health
  • Epic Systems Corporation
  • Fujitsu Ltd.
  • IBM Corporation
  • Informatica LLC
  • Intersystems
  • Microsoft Corporation
  • Oracle Corporation
  • Orion Health
  • Red Hat, Inc.
  • Software AG
  • TIBCO Software, Inc.
  • Zoeticx, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP12300

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Healthcare Middleware Market to Reach $5.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Healthcare Middleware estimated at US$3.1 Billion in the year 2022, is projected to reach a revised size of US$5.8 Billion by 2030, growing at aCAGR of 8.1% over the period 2022-2030. Platform Middleware, one of the segments analyzed in the report, is projected to record 6.8% CAGR and reach US$2.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Integration Middleware segment is readjusted to a revised 9.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $942.3 Million, While China is Forecast to Grow at 7.6% CAGR

The Healthcare Middleware market in the U.S. is estimated at US$942.3 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.5% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Select Competitors (Total 47 Featured) -

  • Ascom Holding AG
  • Cerner Corporation
  • Corepoint Health
  • Epic Systems Corporation
  • Fujitsu Ltd.
  • IBM Corporation
  • Informatica LLC
  • Intersystems
  • Microsoft Corporation
  • Oracle Corporation
  • Orion Health
  • Red Hat, Inc.
  • Software AG
  • TIBCO Software, Inc.
  • Zoeticx, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Healthcare Middleware - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Healthcare Middleware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Healthcare Middleware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Financial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Financial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Operational & Administrative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Operational & Administrative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Healthcare Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Healthcare Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Healthcare Middleware Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Platform Middleware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World 8-Year Perspective for Platform Middleware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Integration Middleware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World 8-Year Perspective for Integration Middleware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Communication Middleware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 25: World 8-Year Perspective for Communication Middleware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World 8-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Life Science Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World 8-Year Perspective for Life Science Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 31: World 8-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Healthcare Middleware Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 35: USA 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 37: USA 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Canada 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Canada 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Canada 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • JAPAN
    • Healthcare Middleware Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Japan 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Japan 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Japan 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • CHINA
    • Healthcare Middleware Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 59: China 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 61: China 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • EUROPE
    • Healthcare Middleware Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Healthcare Middleware by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 65: Europe 8-Year Perspective for Healthcare Middleware by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Europe 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Europe 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Europe 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • FRANCE
    • Healthcare Middleware Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 77: France 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 79: France 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • GERMANY
    • Healthcare Middleware Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Germany 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Germany 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Germany 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • ITALY
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Italy 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Italy 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Italy 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • UNITED KINGDOM
    • Healthcare Middleware Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: UK 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 101: UK 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 103: UK 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Healthcare Middleware Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Healthcare Middleware by Type - Platform Middleware, Integration Middleware, Communication Middleware and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of World 8-Year Perspective for Healthcare Middleware by Type - Percentage Breakdown of Value Sales for Platform Middleware, Integration Middleware, Communication Middleware and Other Types for the Years 2023 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Healthcare Middleware by Deployment - On-Premise, Cloud and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Rest of World 8-Year Perspective for Healthcare Middleware by Deployment - Percentage Breakdown of Value Sales for On-Premise, Cloud and Hybrid for the Years 2023 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Healthcare Middleware by Application - Clinical, Financial and Operational & Administrative - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 127: Rest of World 8-Year Perspective for Healthcare Middleware by Application - Percentage Breakdown of Value Sales for Clinical, Financial and Operational & Administrative for the Years 2023 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Healthcare Middleware by End-Use - Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of World 8-Year Perspective for Healthcare Middleware by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Life Science Organizations and Clinical Laboratories for the Years 2023 & 2030

IV. COMPETITION